🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a prospective Phase II study evaluating Siltuximab for CRS and ICAN...
Status
Recruiting
Location
Institute of Hematology and Blood Diseases Hospital Chinese Academy of Medical Sciences
Start Date
2025-08-10
Trial ID
NCT07106671
Treatments Being Tested
The study is an open-label Phase 1 single dose-escalation safety study of C...
Status
Completed
Location
Mayo Clinic Florida
Start Date
2018-10-15
Trial ID
NCT03464916
Treatments Being Tested
RATIONALE: Placing a tumor antigen chimeric receptor that has been created ...
Status
Unknown
Location
Biotherapeutic Department and Pediatrics Department of Chinese PLA General Hospital
Start Date
2015-10
Trial ID
NCT02580747
Treatments Being Tested
The purpose of this study is to determine whether autologous T cells bearin...
Status
Unknown
Location
PersonGen Biomedicine (Suzhou) Co., Ltd.
Start Date
2015-10
Trial ID
NCT02587689
Treatments Being Tested
This is an open-label, single-arm, Phase 2 study to evaluate the efficacy a...
Status
Recruiting
Location
The First Hospital of Jilin University
Start Date
2025-12-29
Trial ID
NCT07509086
Treatments Being Tested
This phase II trial tests how well giving dasatinib and quercetin with cycl...
Status
Recruiting
Location
Mayo Clinic in Rochester
Start Date
2025-09-18
Trial ID
NCT06940297
This clinical study is to investigate the safety and tolerability of CAR mo...
Status
Terminated
Location
Shanghai Zhongshan Hospital
Start Date
2019-05-16
Trial ID
NCT03960060
Treatments Being Tested
This phase I trial studies the side effects and best dose of genetically mo...
Status
Active Not Recruiting
Location
City of Hope Medical Center
Start Date
2015-05-18
Trial ID
NCT02208362
Treatments Being Tested
This is a single-center, open-label clinical study of anti-HER2-CAR-T cells...
Status
Recruiting
Location
Phase I Clinical Trials Center Of The First Hospital of China Medical University
Start Date
2024-01-16
Trial ID
NCT06101082
Treatments Being Tested
RATIONALE: Placing a tumor antigen chimeric receptor that has been created ...
Status
Unknown
Location
Chinese PLA General Hospital
Start Date
2013-06
Trial ID
NCT01886976
Treatments Being Tested